Search

Your search keyword '"Nihoyannopoulos, Petro"' showing total 9 results
Start Over Author "Nihoyannopoulos, Petro"
9 results on '"Nihoyannopoulos, Petro"'

1. The continuous heart failure spectrum: moving beyond an ejection fraction classification

Author

Gilles W. De Keulenaer, Robert O. Bonow, Nazha Hamdani, Filippos Triposkiadis, Johann Bauersachs, Richard T. Lee, Vincent F.M. Segers, Ida G. Lunde, Douglas L. Mann, John Parissis, Petros Nihoyannopoulos, Johannes Backs, Alexandre Mebazaa, Vijay K. Chopra, Stephane Heymans, Randall C. Starling, Javed Butler, Ajay M. Shah, Giuseppe M.C. Rosano, Christoph Maack, Alexander R. Lyon, Jean L. Rouleau, Jean Noel Trochu, Wolfgang A. Linke, Zoltán Papp, Rudolf A. de Boer, Marvin A. Konstam, Robert J. Mentz, Thomas Thum, Francois M. Abboud, Petar M. Seferović, Jean-Sébastien Hulot, Carlo G. Tocchetti, Stamatis Adamopoulos, Dirk L. Brutsaert, Faiez Zannad, Gerd Hasenfuss, John Atherton, Leon J. De Windt, Daniel Burkhoff, Paul W. Armstrong, Thierry Pedrazzini, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Triposkiadis, Filippo, Butler, Javed, Abboud, Francois M, Armstrong, Paul W, Adamopoulos, Stamati, Atherton, John J, Backs, Johanne, Bauersachs, Johann, Burkhoff, Daniel, Bonow, Robert O, Chopra, Vijay K, de Boer, Rudolf A, de Windt, Leon, Hamdani, Nazha, Hasenfuss, Gerd, Heymans, Stephane, Hulot, Jean-Sébastien, Konstam, Marvin, Lee, Richard T, Linke, Wolfgang A, Lunde, Ida G, Lyon, Alexander R, Maack, Christoph, Mann, Douglas L, Mebazaa, Alexandre, Mentz, Robert J, Nihoyannopoulos, Petro, Papp, Zoltan, Parissis, John, Pedrazzini, Thierry, Rosano, Giuseppe, Rouleau, Jean, Seferovic, Petar M, Shah, Ajay M, Starling, Randall C, Tocchetti, Carlo G, Trochu, Jean-Noel, Thum, Thoma, Zannad, Faiez, Brutsaert, Dirk L, Segers, Vincent F, and De Keulenaer, Gilles W

Subjects
Clinical Review, Ejection fraction, Cardiac & Cardiovascular Systems, [SDV]Life Sciences [q-bio], Disease, Comorbidity, 030204 cardiovascular system & hematology, EXERCISE CAPACITY, law.invention, Ventricular Dysfunction, Left, 0302 clinical medicine, Randomized controlled trial, law, Reference Values, Medicine, Myocytes, Cardiac, 030212 general & internal medicine, 1102 Cardiorespiratory Medicine and Haematology, OUTCOMES, Ventricular Remodeling, Stroke volume, ASSOCIATION, 3. Good health, PREVALENCE, VENTRICULAR-FUNCTION, Cardiology, Disease Progression, cardiovascular system, Cardiology and Cardiovascular Medicine, ECHOCARDIOGRAPHY, Life Sciences & Biomedicine, circulatory and respiratory physiology, medicine.medical_specialty, Heart failure, Pathophysiology, GLOBAL LONGITUDINAL STRAIN, 03 medical and health sciences, Internal medicine, CO-MORBIDITIES, Humans, cardiovascular diseases, Endothelium, Ventricular remodeling, Science & Technology, business.industry, Stroke Volume, medicine.disease, DYSFUNCTION, COMORBIDITIES, Cardiovascular System & Hematology, Cardiovascular System & Cardiology, Human medicine, Endothelium, Vascular, business, Heart failure with preserved ejection fraction
Abstract

Randomized clinical trials initially used heart failure (HF) patients with low left ventricular ejection fraction (LVEF) to select study populations with high risk to enhance statistical power. However, this use of LVEF in clinical trials has led to oversimplification of the scientific view of a complex syndrome. Descriptive terms such as ‘HFrEF’ (HF with reduced LVEF), ‘HFpEF’ (HF with preserved LVEF), and more recently ‘HFmrEF’ (HF with mid-range LVEF), assigned on arbitrary LVEF cut-off points, have gradually arisen as separate diseases, implying distinct pathophysiologies. In this article, based on pathophysiological reasoning, we challenge the paradigm of classifying HF according to LVEF. Instead, we propose that HF is a heterogeneous syndrome in which disease progression is associated with a dynamic evolution of functional and structural changes leading to unique disease trajectories creating a spectrum of phenotypes with overlapping and distinct characteristics. Moreover, we argue that by recognizing the spectral nature of the disease a novel stratification will arise from new technologies and scientific insights that will shape the design of future trials based on deeper understanding beyond the LVEF construct alone.

Published
2021

2. The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

Author

Čelutkienė, Jelena, Pudil, Radek, López-Fernández, Teresa, Grapsa, Julia, Nihoyannopoulos, Petros, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrios, Tocchetti, Carlo Gabriele, von Haehling, Stephan, Barberis, Vassilis, Flachskampf, Frank A, Čeponienė, Indrė, Haegler-Laube, Eva, Suter, Thomas, Lapinskas, Tomas, Prasad, Sanjay, de Boer, Rudolf A, Wechalekar, Kshama, Anker, Markus S, Iakobishvili, Zaza, Buccarelli-Ducci, Chiara, Schulz-Menger, Jeanette, Cosyns, Bernard, Gaemperli, Oliver, Belenkov, Yury, Hulot, Jean-Sébastien, Galderisi, Maurizio, Lancellotti, Patrizio, Bax, Jeroen, Marwick, Thomas H, Chioncel, Ovidiu, Jaarsma, Tiny, Mullens, Wilfried, Piepoli, Massimo, Thum, Thomas, Heymans, Stephane, Mueller, Christian, Moura, Brenda, Ruschitzka, Frank, Zamorano, Jose Luis, Rosano, Giuseppe, Coats, Andrew J S, Asteggiano, Riccardo, Seferovic, Petar, Edvardsen, Thor, Lyon, Alexander R, Čelutkienė, Jelena, Pudil, Radek, López-Fernández, Teresa, Grapsa, Julia, Nihoyannopoulos, Petro, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrio, Tocchetti, Carlo Gabriele, von Haehling, Stephan, Barberis, Vassili, Flachskampf, Frank A, Čeponienė, Indrė, Haegler-Laube, Eva, Suter, Thoma, Lapinskas, Toma, Prasad, Sanjay, de Boer, Rudolf A, Wechalekar, Kshama, Anker, Markus S, Iakobishvili, Zaza, Buccarelli-Ducci, Chiara, Schulz-Menger, Jeanette, Cosyns, Bernard, Gaemperli, Oliver, Belenkov, Yury, Hulot, Jean-Sébastien, Galderisi, Maurizio, Lancellotti, Patrizio, Bax, Jeroen, Marwick, Thomas H, Chioncel, Ovidiu, Jaarsma, Tiny, Mullens, Wilfried, Piepoli, Massimo, Thum, Thoma, Heymans, Stephane, Mueller, Christian, Moura, Brenda, Ruschitzka, Frank, Zamorano, Jose Lui, Rosano, Giuseppe, Coats, Andrew J S, Asteggiano, Riccardo, Seferovic, Petar, Edvardsen, Thor, and Lyon, Alexander R

Subjects
nuclear imaging, cardio-oncology, cardiotoxicity, echocardiography, heart failure, imaging, computed tomography, cardiac magnetic resonance, global longitudinal strain
Abstract

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long-term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed. This article is protected by copyright. All rights reserved.

Published
2020

3. EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: A report of literature and current practice review

Author

Steeds, Richard P., Garbi, Madalina, Cardim, Nuno, Kasprzak, Jaroslaw D., Sade, Elif, Nihoyannopoulos, Petros, Popescu, Bogdan Alexandru, Stefanidis, Alexandros, Cosyns, Bernard, Monaghan, Mark, Aakhus, Svend, Edvardsen, Thor, Flachskampf, Frank, Galiuto, Leonarda, Athanassopoulos, George, Lancellotti, Patrizio, Delgado, Victoria, Donal, Erwan, Galderisi, Maurizio, Lombardi, Massimo, Muraru, Denisa, Haugaa, Kristina, Steeds, Richard P., Garbi, Madalina, Cardim, Nuno, Kasprzak, Jaroslaw D., Sade, Elif, Nihoyannopoulos, Petro, Popescu, Bogdan Alexandru, Stefanidis, Alexandro, Cosyns, Bernard, Monaghan, Mark, Aakhus, Svend, Edvardsen, Thor, Flachskampf, Frank, Galiuto, Leonarda, Athanassopoulos, George, Lancellotti, Patrizio, Delgado, Victoria, Donal, Erwan, Galderisi, Maurizio, Lombardi, Massimo, Muraru, Denisa, Haugaa, Kristina, Steeds Richard, P, Garbi, M, Cardim, N, Kasprzak Jaroslaw, D, Sade, E, Nihoyannopoulos, P, Popescu Bogdan, A, Stefanidis, A, Cosyns, B, Monaghan, M, Aakhus, S, Edvardsen, T, Flachskampf, F, Galiuto, L, Athanassopoulos, G, Lancellotti, P, Delgado, V, Donal, E, Galderisi, M, Lombardi, M, Muraru, D, Haugaa, K, Cardio-vascular diseases, and Clinical sciences

Subjects
Adult, medicine.medical_specialty, Radiology, Nuclear Medicine and Imaging, indication, 030204 cardiovascular system & hematology, Health Services Misuse, appropriateness, Appropriate Use Criteria, Management planning, 03 medical and health sciences, transthoracic echocardiography, 0302 clinical medicine, medicine, Medical imaging, Echocardiography transthoracic, Humans, echocardiography, 030212 general & internal medicine, Intensive care medicine, indications, business.industry, General Medicine, Appropriateness criteria, Clinical Practice, Europe, Radiology Nuclear Medicine and imaging, Current practice, Cardiovascular Diseases, appropriatene, Radiology, Guideline Adherence, business, Cardiology and Cardiovascular Medicine
Abstract

The European Association for Cardiovascular Imaging (EACVI) has outlined the rationale for setting appropriate use criteria (AUC) in cardiovascular (CV) imaging. Transthoracic echocardiography (TTE) is the most common imaging modality in CV disease and is a central tool in diagnosis, follow-up, management planning and intervention. The purpose of AUC is to inform referrers, both to avoid under-use, which may result in incomplete or incorrect diagnosis and treatment, and also over-use, which may delay correct diagnosis, lead to 'treatment cascade', and wastes resources. The first step in defining AUC for TTE in the adult has been for a panel of experts in echocardiography to review the evidence, guidelines, recommendations, and position papers from the European Society of Cardiology, EACVI and other specialist societies, and current state-of-the-art clinical practice. The attached document summarizes this work, which will be used to under-pin the development of AUC.

Published
2017

4. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Author

Zamorano, JL, Lancellotti, P, Rodriguez Muñoz, D, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lip, GY, Lyon, AR, Lopez Fernandez, T, Mohty, D, Piepoli, MF, Tamargo, J, Torbicki, A, Suter, TM, Achenbach, S, Agewall, S, Badimon, L, Barón-Esquivias, G, Baumgartner, H, Bax, JJ, Bueno, H, Carerj, S, Dean, V, Erol, Ç, Fitzsimons, D, Gaemperli, O, Kirchhof, P, Kolh, P, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Vaz Carneiro, A, Windecker, S, Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), University of Zurich, Zamorano, Jose Luis, Centre Hospitalier Universitaire de Liège (CHU-Liège), Neuroépidémiologie Tropicale (NET), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Università degli studi di Napoli Federico II, Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes (URMITE), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), British Heart Foundation, Action Against Cancer, Zamorano, Jose Lui, Lancellotti, Patrizio, Rodriguez Muñoz, Daniel, Aboyans, Victor, Asteggiano, Riccardo, Galderisi, Maurizio, Habib, Gilbert, Lenihan, Daniel J., Lip, Gregory Y. H., Lyon, Alexander R., Lopez Fernandez, Teresa, Mohty, Dania, Piepoli, Massimo F., Tamargo, Juan, Torbicki, Adam, Suter, Thomas M., Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Barón Esquivias, Gonzalo, Baumgartner, Helmut, Bax, Jeroen J., Bueno, Héctor, Carerj, Scipione, Dean, Veronica, Erol, Çetin, Fitzsimons, Donna, Gaemperli, Oliver, Kirchhof, Paulu, Kolh, Philippe, Nihoyannopoulos, Petro, Ponikowski, Piotr, Roffi, Marco, Vaz Carneiro, António, Windecker, Stephan, Lenihan, Daniel J, Lip, Gregory Y. H, Lyon, Alexander R, Piepoli, Massimo F, University of Naples Federico II = Università degli studi di Napoli Federico II, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
Vascular Endothelial Growth Factor A, Angiotensin receptor, Cardiac & Cardiovascular Systems, cardio-oncology, medicine.medical_treatment, myocardial dysfunction, 030204 cardiovascular system & hematology, ANTHRACYCLINE-INDUCED CARDIOMYOPATHY, chemotherapy, Coronary artery disease, 0302 clinical medicine, RENAL-CELL CARCINOMA, Authors/Task Force Members, Cancer Survivors, Neoplasms, Natriuretic peptide, 610 Medicine & health, early detection, ComputingMilieux_MISCELLANEOUS, Societies, Medical, HER2-POSITIVE BREAST-CANCER, TRASTUZUMAB-INDUCED CARDIOTOXICITY, Chemotherapy regimen, 3. Good health, Europe, medicine.anatomical_structure, 030220 oncology & carcinogenesis, CHEMOTHERAPY-INDUCED CARDIOTOXICITY, Practice Guidelines as Topic, cardiovascular system, Cardiology, surveillance, 10209 Clinic for Cardiology, cancer therapy, CORONARY-ARTERY-DISEASE, ESC Committee for Practice Guidelines (CPG), ischaemia, Immunotherapy, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, arrhythmias, Arrhythmia, Artery, Cardiovascular toxicity, medicine.medical_specialty, Heart Diseases, medicine.drug_class, Advisory Committees, Cancer therapy, Early detection, Antineoplastic Agents, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, 1102 Cardiovascular Medicine And Haematology, 2705 Cardiology and Cardiovascular Medicine, European Society of Cardiology, 03 medical and health sciences, LEFT-VENTRICULAR DYSFUNCTION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, TYROSINE KINASE INHIBITORS, Humans, cardiovascular diseases, Intensive care medicine, ACUTE LYMPHOBLASTIC-LEUKEMIA, Cardiotoxicity, Science & Technology, CONGESTIVE-HEART-FAILURE, Radiotherapy, business.industry, Arrhythmias, Cardio-oncology, Chemotherapy, Ischaemia, Myocardial dysfunction, Surveillance, Cancer, 10181 Clinic for Nuclear Medicine, Congresses as Topic, medicine.disease, Radiation therapy, Cardiovascular System & Hematology, Cardiovascular System & Cardiology, Position paper, business, human activities, Document Reviewers
Abstract

2-D : two-dimensional 3-D : three-dimensional 5-FU : 5-fluorouracil ACE : angiotensin-converting enzyme ARB : angiotensin II receptor blocker ASE : American Society of Echocardiography BNP : B-type natriuretic peptide CABG : coronary artery bypass graft CAD : coronary artery

Published
2016

5. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Author

Roffi, Marco, Patrono, Carlo, Collet, Jean Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlos, Chew, Derek P., Gencer, Baris, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F., Windecker, Stephan, Zamorano, Jose Luis, Aboyans, Victor, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Barón Esquivias, Gonzalo, Baumgartner, Helmut, Bueno, Héctor, Carerj, Scipione, Dean, Veronica, Erol, Çetin, Fitzsimons, Donna, Gaemperli, Oliver, Kirchhof, Paulus, Kolh, Philippe, Lip, Gregory Y. H., Nihoyannopoulos, Petros, Piepoli, Massimo F., Ponikowski, Piotr, Torbicki, Adam, Carneiro, Antonio Vaz, Chilingaryan, Aram, Weidinger, Franz, Najafov, Ruslan, Sinnaeve, Peter R., Terzić, Ibrahim, Postadzhiyan, Arman, Miličić, Davor, Eftychiou, Christos, Widimsky, Petr, Bang, Lia, El Etriby, Adel, Marandi, Toomas, Pietilä, Mikko, Kedev, Sasko, Koning, René, Aladashvili, Alexander, Neumann, Franz Josef, Tsioufis, Kostantinos, Becker, Dávid, Guðnason, Thorarinn, Matetzky, Shlomi, Bolognese, Leonardo, Mussagaliyeva, Aisulu, Beishenkulov, Medet, Latkovskis, Gustavs, Serpytis, Pranas, Pereira, Bruno, Magri, Caroline Jane, Grosu, Aurel, Abir Khalil, Saadia, Larsen, Alf Inge, Budaj, Andrzej, Mimoso, Jorge M. Vieira, Ginghina, Carmen, Averkov, Oleg, Nedeljkovic, Milan A., Studenčan, Martin, Barrabés, José A., Held, Claes, Rickli, Hans, Peters, Ron J. G., Mourali, Mohamed Sami, Atalar, Enver, Swanson, Neil, Parkhomenko, Alexander, Baigent, Colin, Casselman, Filip, Cuisset, Thomas, Halle, Martin, BUGIARDINI, RAFFAELE, Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlo, Chew, Derek P., Gencer, Bari, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F., Windecker, Stephan, Zamorano, Jose Lui, Aboyans, Victor, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Barón-Esquivias, Gonzalo, Baumgartner, Helmut, Bueno, Héctor, Carerj, Scipione, Dean, Veronica, Erol, Çetin, Fitzsimons, Donna, Gaemperli, Oliver, Kirchhof, Paulu, Kolh, Philippe, Lip, Gregory Y. H., Nihoyannopoulos, Petro, Piepoli, Massimo F., Ponikowski, Piotr, Torbicki, Adam, Carneiro, Antonio Vaz, Chilingaryan, Aram, Weidinger, Franz, Najafov, Ruslan, Sinnaeve, Peter R., Terzić, Ibrahim, Postadzhiyan, Arman, Miličić, Davor, Eftychiou, Christo, Widimsky, Petr, Bang, Lia, El Etriby, Adel, Marandi, Tooma, Pietilä, Mikko, Kedev, Sasko, Koning, René, Aladashvili, Alexander, Neumann, Franz-Josef, Tsioufis, Kostantino, Becker, Dávid, Guðnason, Thorarinn, Matetzky, Shlomi, Bolognese, Leonardo, Mussagaliyeva, Aisulu, Beishenkulov, Medet, Latkovskis, Gustav, Serpytis, Prana, Pereira, Bruno, Magri, Caroline Jane, Grosu, Aurel, Abir-Khalil, Saadia, Larsen, Alf Inge, Budaj, Andrzej, Mimoso, Jorge M. Vieira, Ginghina, Carmen, Averkov, Oleg, Nedeljkovic, Milan A., Studenčan, Martin, Barrabés, José A., Held, Clae, Rickli, Han, Peters, Ron J. G., Mourali, Mohamed Sami, Atalar, Enver, Swanson, Neil, Parkhomenko, Alexander, Baigent, Colin, Bugiardini, Raffaele, Casselman, Filip, Cuisset, Thoma, and Halle, Martin

Subjects
High-sensitivity troponin, Ticagrelor, Chest pain unit, Platelet inhibition, Glycoprotein IIb/IIIa inhibitor, Guideline, Myocardial ischaemia, Diabete, Nitrate, Early invasive strategy, Vorapaxar, Anticoagulation, Rivaroxaban, Stent, Apixaban, Beta-blocker, Enoxaparin, Bypass surgery, Rhythm monitoring, Aspirin, Heparin, Revascularization, Angioplasty, Atherothrombosi, Statin, Cangrelor, Acute cardiac care, Recommendation, Clopidogrel, Dabigatran, Fondaparinux, Acute coronary syndrome, Non-ST-elevation myocardial infarction, European society of cardiology, Cardiology and Cardiovascular Medicine, Bivalirudin, Prasugrel, Unstable angina
Abstract

N/A

Published
2016

6. Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM)

Author

Habib, Gilbert, Lancellotti, Patrizio, Antunes Manuel, J., Bongiorni Maria Grazia, Casalta, Jean-Paul, Del Zotti Francesco, Dulgheru, Raluca, El Khoury Gebrine, Erba Paola Anna, Iung, Bernard, Miro Jose, M., Mulder Barbara, J., Plonska-Gosciniak, Edyta, Price, Susanna, Roos-Hesselink, Jolien, Snygg-Martin, Ulrika, Thuny, Franck, Mas Pilar Tornos, Vilacosta, Isidre, Zamorano Jose Luis, Erol, Çetin, Nihoyannopoulos, Petros, Aboyans, Victor, Agewall, Stefan, Athanassopoulos, George, Aytekin, Saide, Benzer, Werner, Bueno, Héctor, Broekhuizen, Lidewij, Carerj, Scipione, Cosyns, Bernard, De Backer Julie, De Bonis Michele, Dimopoulos, Konstantinos, Donal, Erwan, Drexel, Heinz, Flachskampf Frank Arnold, Hall, Roger, Halvorsen, Sigrun, Hoen, Bruno, Kirchhof, Paulus, Lainscak, Mitja, Leite-Moreira Adelino, F., Lip Gregory, Y. H., Mestres Carlos, A., Piepoli Massimo, F., Punjabi Prakash, P., Rapezzi, Claudio, Rosenhek, Raphael, Siebens, Kaat, Tamargo, Juan, Walker David, M., Habib, Gilbert, Lancellotti, Patrizio, Antunes, Manuel J., Bongiorni, Maria Grazia, Casalta, Jean-Paul, Del Zotti, Francesco, Dulgheru, Raluca, El Khoury, Gebrine, Erba, Paola Anna, Iung, Bernard, Miro, Jose M., Mulder, Barbara J., Plonska-Gosciniak, Edyta, Price, Susanna, Roos-Hesselink, Jolien, Snygg-Martin, Ulrika, Thuny, Franck, Mas, Pilar Torno, Vilacosta, Isidre, Zamorano, Jose Lui, Erol, Çetin, Nihoyannopoulos, Petro, Aboyans, Victor, Agewall, Stefan, Athanassopoulos, George, Aytekin, Saide, Benzer, Werner, Bueno, Héctor, Broekhuizen, Lidewij, Carerj, Scipione, Cosyns, Bernard, De Backer, Julie, De Bonis, Michele, Dimopoulos, Konstantino, Donal, Erwan, Drexel, Heinz, Flachskampf, Frank Arnold, Hall, Roger, Halvorsen, Sigrun, Hoen, Bruno, Kirchhof, Paulu, Lainscak, Mitja, Leite-Moreira, Adelino F., Lip, Gregory Y.H., Mestres, Carlos A., Piepoli, Massimo F., Punjabi, Prakash P., Rapezzi, Claudio, Rosenhek, Raphael, Siebens, Kaat, Tamargo, Juan, and Walker, David M.

Subjects
Endocarditis, Prognosi, Decision Tree, Algorithms, Decision Trees, Endocarditis, Bacterial, Heart Valve Diseases, Humans, Prognosis, Cardiology and Cardiovascular Medicine, Bacterial, NO, Algorithm, Heart Valve Disease, Human
Abstract

Le linee guida hanno l’obiettivo di riassumere e valutare le evidenze disponibili al momento della loro stesura in merito ad una specifica materia al fine di coadiuvare il medico nella scelta della migliore strategia gestionale per ciascun paziente, affetto da una determinata patologia, tenendo in considerazione non solo l’impatto sull’outcome ma anche il rapporto rischio-beneficio connesso ad una particolare procedura diagnostica o terapeutica. Le linee guida e le raccomandazioni mirano ad assistere il medico nel processo decisionale della pratica clinica quotidiana, anche se il giudizio finale spetta comunque al medico curante dopo aver consultato il paziente e/o chi lo assiste. Negli ultimi anni la Società Europea di Cardiologia (ESC) e diverse organizzazioni e società scientifiche hanno emanato numerose linee guida. In considerazione del loro impatto sulla pratica clinica, sono stati definiti alcuni criteri di qualità per la realizzazione delle linee guida affinché ogni decisione risultasse trasparente a quanti ne usufruiscono. Le raccomandazioni per la stesura e l’emissione delle linee guida ESC sono disponibili sul sito web dell’ESC (http://www.escardio.org/Guidelines-&- Education/Clinical-Practice-Guidelines/Guidelines-development/ Writing-ESC-Guidelines). Le linee guida ESC esprimono la posizione ufficiale della Società in riferimento ad uno specifico argomento e sono soggette ad aggiornamenti periodici.

Published
2016

7. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa

Author

Stefan Agewall, Isidre Vilacosta, Raluca Elena Dulgheru, Edyta Plonska-Gosciniak, Manuel J. Antunes, Sigrun Halvorsen, Franck Thuny, Bernard Cosyns, Ulrika Snygg-Martin, Scipione Carerj, Kaat Siebens, Çetin Erol, José Luis Zamorano, Petros Nihoyannopoulos, Werner Benzer, Carlos A. Mestres, Mitja Lainscak, Raphael Rosenhek, Erwan Donal, Gregory Y.H. Lip, Massimo F Piepoli, Barbara J. Mulder, Konstantinos Dimopoulos, Paulus Kirchhof, Maria Grazia Bongiorni, David M. Walker, Paola Anna Erba, Pilar Tornos Mas, Michele De Bonis, Heinz Drexel, Frank A. Flachskampf, Jolien W. Roos-Hesselink, George Athanassopoulos, Bruno Hoen, Saide Aytekin, Victor Aboyans, Adelino F. Leite-Moreira, José M. Miró, Héctor Bueno, Julie De Backer, Roger Hall, Bernard Iung, Jean Paul Casalta, Prakash P Punjabi, Claudio Rapezzi, Susanna Price, Lidewij Broekhuizen, Gebrine El Khoury, Francesco Del Zotti, Patrizio Lancellotti, Juan Tamargo, Gilbert Habib, Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J. -P., Zotti, F. D., Dulgheru, R., Khoury, G. E., Erba, P. A., Iung, B., Miro, J. M., Mulder, B. J., Plonska-Gosciniak, E., Price, S., Roos-Hesselink, J., Snygg-Martin, U., Thuny, F., Mas, P. T., Vilacosta, I., Zamorano, J. L., Erol, C., Nihoyannopoulos, P., Aboyans, V., Agewall, S., Athanassopoulos, G., Aytekin, S., Benzer, W., Bueno, H., Broekhuizen, L., Carerj, S., Cosyns, B., De Backer, J., De Bonis, M., Dimopoulos, K., Donal, E., Drexel, H., Flachskampf, F. A., Hall, R., Halvorsen, S., Hoen, B., Kirchhof, P., Lainscak, M., Leite-Moreira, A. F., Lip, G. Y. H., Mestres, C. A., Piepoli, M. F., Punjabi, P. P., Rapezzi, C., Rosenhek, R., Siebens, K., Tamargo, J., Walker, D. M., Habib, Gilbert, Lancellotti, Patrizio, Antunes, Manuel J., Bongiorni, Maria Grazia, Casalta, Jean-Paul, Zotti, Francesco Del, Dulgheru, Raluca, Khoury, Gebrine El, Erba, Paola Anna, Iung, Bernard, Miró, Jose M., Mulder, Barbara J., Plonska-Gosciniak, Edyta, Price, Susanna, Roos-Hesselink, Jolien, Snygg-Martin, Ulrika, Thuny, Franck, Mas, Pilar Torno, Vilacosta, Isidre, Zamorano, José Lui, Erol, Çetin, Nihoyannopoulos, Petro, Aboyans, Victor, Agewall, Stefan, Athanassopoulos, George, Aytekin, Saide, Benzer, Werner, Bueno, Héctor, Broekhuizen, Lidewij, Carerj, Scipione, Cosyns, Bernard, De Backer, Julie, De Bonis, Michele, Dimopoulos, Konstantino, Donal, Erwan, Drexel, Heinz, Flachskampf, Frank Arnold, Hall, Roger, Halvorsen, Sigrun, Hoen, Bruno, Kirchhof, Paulu, Lainscak, Mitja, Leite-Moreira, Adelino F., Lip, Gregory Y.H., Mestres, Carlos A., Piepoli, Massimo F., Punjabi, Prakash P., Rapezzi, Claudio, Rosenhek, Raphael, Siebens, Kaat, Tamargo, Juan, and Walker, David M.

Subjects
business.industry, practice guideline, Endocarditis. Imagen cardiaca. Valvulopatía. Ecocardiografía. Pronóstico. Guías de práctica clínica. Infección. Imagen de cardiología nuclear. Cirugía cardiaca. Dispositivo cardiaco. Válvulas cardiacas protésicas. Cardiopatía congénita. Embarazo. Profilaxis. Prevención, Cardiology and Cardiovascular Medicine, bacterial endocarditis, Settore MED/11 - Malattie dell'Apparato Cardiovascolare, 030204 cardiovascular system & hematology, NO, 03 medical and health sciences, 0302 clinical medicine, Medicine, 030212 general & internal medicine, business, Humanities
Abstract

Las Guías de Práctica Clínica (GPC) tienen como objetivo reunir y evaluar toda la evidencia relevante disponible durante el proceso deelaboración sobre un tema particular para ayudar a los médicos a seleccionar la mejor estrategia posible de tratamiento para un paciente en particular, que sufre una enfermedad determinada, teniendo en cuenta no solo el resultado final, sino también sopesando los riesgos y los beneficios de un procedimiento diagnóstico o terapéutico concreto. Las GPC y las recomendaciones deben ayudar a los profesionales de la salud en la toma de decisiones clínicas en su ejercicio diario. No obstante, la decisión final sobre un paciente concreto la debe tomar el médico responsable de su cuidado, en consulta con el propio paciente o, cuando proceda, con la persona responsable de sus cuidados. En los últimos años, la Sociedad Europea de Cardiología (ESC), además de otras sociedades y organizaciones científicas, ha publicado un gran número de GPC. Debido al impacto de las GPC, se han establecido criterios de calidad para su elaboración de forma que todas las decisiones se presenten de modo claro y transparente al usuario. Se puede encontrar las recomendaciones de la ESC para la elaboración y publicación de GPC en la sección de guías de la página web de la ESC (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice- Guidelines/Guidelines-development/Writing-ESC-Guidelines). Las GPC de la ESC representan la postura oficial de la ESC sobre un tema particular y se actualizan con regularidad.

Published
2016

8. Wytyczne ESC dotyczace rozpoznawania i postȩpowania w kardiomiopatii przerostowej w 2014 roku

Author

Elliott Perry, M, Anastasakis, Aris, Borger Michael, A., Borggrefe, Martin, Cecchi, Franco, Charron, Philippe, Hagege Albert Alain, Lafont, Antoine, Limongelli, Giuseppe, Mahrholdt, Heiko, Mckenna William, J., Mogensen, Jens, Nihoyannopoulos, Petros, Nistri, Stefano, Pieper Petronella, G., Pieske, Burkert, Rapezzi, Claudio, Rutten Frans, H., Tillmanns, Christoph, Watkins, Hugh, Elliott, Perry M, Anastasakis, Ari, Borger, Michael A., Borggrefe, Martin, Cecchi, Franco, Charron, Philippe, Hagege, Albert Alain, Lafont, Antoine, Limongelli, Giuseppe, Mahrholdt, Heiko, Mckenna, William J., Mogensen, Jen, Nihoyannopoulos, Petro, Nistri, Stefano, Pieper, Petronella G., Pieske, Burkert, Rapezzi, Claudio, Rutten, Frans H., Tillmanns, Christoph, and Watkins, Hugh

Subjects
Cardiology and Cardiovascular Medicine, NO
Abstract

Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Published
2014

9. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

Author

Giuseppe, Mancia, Robert, Fagard, Krzysztof, Narkiewicz, Josep, Redon, Alberto, Zanchetti, Michael, Böhm, Thierry, Christiaens, Renata, Cifkova, Guy, De Backer, Anna, Dominiczak, Maurizio, Galderisi, Diederick E, Grobbee, Tiny, Jaarsma, Paulus, Kirchhof, Sverre E, Kjeldsen, Stéphane, Laurent, Athanasios J, Manolis, Peter M, Nilsson, Luis Miguel, Ruilope, Roland E, Schmieder, Per Anton, Sirnes, Peter, Sleight, Margus, Viigimaa, Bernard, Waeber, Faiez, Zannad, Michel, Burnier, Ettore, Ambrosioni, Mark, Caufield, Antonio, Coca, Michael Hecht, Olsen, Costas, Tsioufis, Philippe, van de Borne, Jose Luis, Zamorano, Stephan, Achenbach, Helmut, Baumgartner, Jeroen J, Bax, Héctor, Bueno, Veronica, Dean, Christi, Deaton, Cetin, Erol, Roberto, Ferrari, David, Hasdai, Arno W, Hoes, Juhani, Knuuti, Philippe, Kolh, Patrizio, Lancellotti, Ales, Linhart, Petros, Nihoyannopoulos, Massimo F, Piepoli, Piotr, Ponikowski, Juan Luis, Tamargo, Michal, Tendera, Adam, Torbicki, William, Wijns, Stephan, Windecker, Denis L, Clement, Thierry C, Gillebert, Enrico Agabiti, Rosei, Stefan D, Anker, Johann, Bauersachs, Jana Brguljan, Hitij, Mark, Caulfield, Marc, De Buyzere, Sabina, De Geest, Geneviève Anne, Derumeaux, Serap, Erdine, Csaba, Farsang, Christian, Funck-Brentano, Vjekoslav, Gerc, Giuseppe, Germano, Stephan, Gielen, Herman, Haller, Jens, Jordan, Thomas, Kahan, Michel, Komajda, Dragan, Lovic, Heiko, Mahrholdt, Jan, Ostergren, Gianfranco, Parati, Joep, Perk, Jorge, Polonia, Bogdan A, Popescu, Zeljko, Reiner, Lars, Rydén, Yuriy, Sirenko, Alice, Stanton, Harry, Struijker-Boudier, Charalambos, Vlachopoulos, Massimo, Volpe, David A, Wood, Mancia, G, Fagard, R, Narkiewicz, K, Redon, J, Zanchetti, A, Böhm, M, Christiaens, T, Cifkova, R, De Backer, G, Dominiczak, A, Galderisi, M, Grobbee, D, Jaarsma, T, Kirchhof, P, Kjeldsen, S, Laurent, S, Manolis, A, Nilsson, P, Ruilope, L, Schmieder, R, Sirnes, P, Sleight, P, Viigimaa, M, Waeber, B, Zannad, F, Burnier, M, Ambrosioni, E, Caufield, M, Coca, A, Olsen, M, Tsioufis, C, Van De Borne, P, Zamorano, J, Achenbach, S, Baumgartner, H, Bax, J, Bueno, H, Dean, V, Deaton, C, Erol, C, Ferrari, R, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Lancellotti, P, Linhart, A, Nihoyannopoulos, P, Piepoli, M, Ponikowski, P, Tamargo, J, Tendera, M, Torbicki, A, Wijns, W, Windecker, S, Clement, D, Gillebert, T, Rosei, E, Anker, S, Bauersachs, J, Hitij, J, Caulfield, M, De Buyzere, M, De Geest, S, Derumeaux, G, Erdine, S, Farsang, C, Funck Brentano, C, Gerc, V, Germano, G, Gielen, S, Haller, H, Jordan, J, Kahan, T, Komajda, M, Lovic, D, Mahrholdt, H, Ostergren, J, Parati, G, Perk, J, Polonia, J, Popescu, B, Reiner, Ž, Rydén, L, Sirenko, Y, Stanton, A, Struijker Boudier, H, Vlachopoulos, C, Volpe, M, Wood, D, Mancia, Giuseppe, Fagard, Robert, Narkiewicz, Krzysztof, Redon, Josep, Zanchetti, Alberto, Böhm, Michael, Christiaens, Thierry, Cifkova, Renata, De Backer, Guy, Dominiczak, Anna, Galderisi, Maurizio, Grobbee, Diederick E., Jaarsma, Tiny, Kirchhof, Paulu, Kjeldsen, Sverre E., Laurent, Stéphane, Manolis, Athanasios J., Nilsson, Peter M., Ruilope, Luis Miguel, Schmieder, Roland E., Sirnes, Per Anton, Sleight, Peter, Viigimaa, Margu, Waeber, Bernard, Zannad, Faiez, Burnier, Michel, Ambrosioni, Ettore, Caufield, Mark, Coca, Antonio, Olsen, Michael Hecht, Tsioufis, Costa, Van De Borne, Philippe, Zamorano, Jose Lui, Achenbach, Stephan, Baumgartner, Helmut, Bax, Jeroen J., Bueno, Héctor, Dean, Veronica, Deaton, Christi, Erol, Cetin, Ferrari, Roberto, Hasdai, David, Hoes, Arno W., Knuuti, Juhani, Kolh, Philippe, Lancellotti, Patrizio, Linhart, Ale, Nihoyannopoulos, Petro, Piepoli, Massimo F., Ponikowski, Piotr, Tamargo, Juan Lui, Tendera, Michal, Torbicki, Adam, Wijns, William, Windecker, Stephan, Clement, Denis L., Gillebert, Thierry C., Rosei, Enrico Agabiti, Anker, Stefan D., Bauersachs, Johann, Hitij, Jana Brguljan, Caulfield, Mark, De Buyzere, Marc, De Geest, Sabina, Derumeaux, Geneviève Anne, Erdine, Serap, Farsang, Csaba, Funck Brentano, Christian, Gerc, Vjekoslav, Germano, Giuseppe, Gielen, Stephan, Haller, Herman, Jordan, Jen, Kahan, Thoma, Komajda, Michel, Lovic, Dragan, Mahrholdt, Heiko, Ostergren, Jan, Parati, Gianfranco, Perk, Joep, Polonia, Jorge, Popescu, Bogdan A., Reiner, Željko, Rydén, Lar, Sirenko, Yuriy, Stanton, Alice, Struijker Boudier, Harry, Vlachopoulos, Charalambo, Volpe, Massimo, and Wood, David A.

Subjects
Male, Systolic hypertension, Medical Informatic, Blood Pressure, Guideline, Retinal Disease, chemistry.chemical_compound, Electrocardiography, Pregnancy, Risk Factors, Antihypertensive treatment, Cardiovascular Disease, Diabetes Complication, Drug Interactions, Metabolic Syndrome, Brain Diseases, Sleep Apnea, Obstructive, Follow-up, Metabolic Syndrome X, Brain Disease, Organ damage, Blood Pressure Monitoring, Ambulatory, Middle Aged, Device therapy, Antihypertensive Agent, Heart Disease, Drug Interaction, Cardiovascular Diseases, Echocardiography, Cerebrovascular Disorder, Hypertension, Cardiology, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, Human, medicine.drug, Adult, medicine.medical_specialty, Ambulatory blood pressure, Heart Diseases, Hormone Replacement Therapy, 610 Medicine & health, Risk Assessment, Perioperative Care, Diabetes Complications, Young Adult, Retinal Diseases, Internal medicine, Weight Loss, medicine, Humans, Blood pressure measurement, Renal Insufficiency, Chronic, Exercise, Physical Examination, Perindopril/indapamide, Antihypertensive Agents, Aged, Patient Care Team, business.industry, Platelet Aggregation Inhibitor, Risk Factor, Cardiovascular complication, Hypertension, Pregnancy-Induced, Aliskiren, Cardiovascular risk, Lifestyle, medicine.disease, Weight Lo, Diet, Candesartan, Cerebrovascular Disorders, Sexual Dysfunction, Physiological, Blood pressure, chemistry, Heart failure, Hyperglycemia, Smoking Cessation, Telmisartan, business, Delivery of Health Care, Risk Reduction Behavior, Medical Informatics, Platelet Aggregation Inhibitors, Contraceptives, Oral
Abstract

ABCD : Appropriate Blood pressure Control in Diabetes ABI : ankle–brachial index ABPM : ambulatory blood pressure monitoring ACCESS : Acute Candesartan Cilexetil Therapy in Stroke Survival ACCOMPLISH : Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension ACCORD : Action to Control Cardiovascular Risk in Diabetes ACE : angiotensin-converting enzyme ACTIVE I : Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events ADVANCE : Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation AHEAD : Action for HEAlth in Diabetes ALLHAT : Antihypertensive and Lipid-Lowering Treatment to Prevent Heart ATtack ALTITUDE : ALiskiren Trial In Type 2 Diabetes Using Cardio-renal Endpoints ANTIPAF : ANgioTensin II Antagonist In Paroxysmal Atrial Fibrillation APOLLO : A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People ARB : angiotensin receptor blocker ARIC : Atherosclerosis Risk In Communities ARR : aldosterone renin ratio ASCOT : Anglo-Scandinavian Cardiac Outcomes Trial ASCOT-LLA : Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm ASTRAL : Angioplasty and STenting for Renal Artery Lesions A-V : atrioventricular BB : beta-blocker BMI : body mass index BP : blood pressure BSA : body surface area CA : calcium antagonist CABG : coronary artery bypass graft CAPPP : CAPtopril Prevention Project CAPRAF : CAndesartan in the Prevention of Relapsing Atrial Fibrillation CHD : coronary heart disease CHHIPS : Controlling Hypertension and Hypertension Immediately Post-Stroke CKD : chronic kidney disease CKD-EPI : Chronic Kidney Disease—EPIdemiology collaboration CONVINCE : Controlled ONset Verapamil INvestigation of CV Endpoints CT : computed tomography CV : cardiovascular CVD : cardiovascular disease D : diuretic DASH : Dietary Approaches to Stop Hypertension DBP : diastolic blood pressure DCCT : Diabetes Control and Complications Study DIRECT : DIabetic REtinopathy Candesartan Trials DM : diabetes mellitus DPP-4 : dipeptidyl peptidase 4 EAS : European Atherosclerosis Society EASD : European Association for the Study of Diabetes ECG : electrocardiogram EF : ejection fraction eGFR : estimated glomerular filtration rate ELSA : European Lacidipine Study on Atherosclerosis ESC : European Society of Cardiology ESH : European Society of Hypertension ESRD : end-stage renal disease EXPLOR : Amlodipine–Valsartan Combination Decreases Central Systolic Blood Pressure more Effectively than the Amlodipine–Atenolol Combination FDA : U.S. Food and Drug Administration FEVER : Felodipine EVent Reduction study GISSI-AF : Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation HbA1c : glycated haemoglobin HBPM : home blood pressure monitoring HOPE : Heart Outcomes Prevention Evaluation HOT : Hypertension Optimal Treatment HRT : hormone replacement therapy HT : hypertension HYVET : HYpertension in the Very Elderly Trial IMT : intima-media thickness I-PRESERVE : Irbesartan in Heart Failure with Preserved Systolic Function INTERHEART : Effect of Potentially Modifiable Risk Factors associated with Myocardial Infarction in 52 Countries INVEST : INternational VErapamil SR/T Trandolapril ISH : Isolated systolic hypertension JNC : Joint National Committee JUPITER : Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin LAVi : left atrial volume index LIFE : Losartan Intervention For Endpoint Reduction in Hypertensives LV : left ventricle/left ventricular LVH : left ventricular hypertrophy LVM : left ventricular mass MDRD : Modification of Diet in Renal Disease MRFIT : Multiple Risk Factor Intervention Trial MRI : magnetic resonance imaging NORDIL : The Nordic Diltiazem Intervention study OC : oral contraceptive OD : organ damage ONTARGET : ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial PAD : peripheral artery disease PATHS : Prevention And Treatment of Hypertension Study PCI : percutaneous coronary intervention PPAR : peroxisome proliferator-activated receptor PREVEND : Prevention of REnal and Vascular ENdstage Disease PROFESS : Prevention Regimen for Effectively Avoiding Secondary Strokes PROGRESS : Perindopril Protection Against Recurrent Stroke Study PWV : pulse wave velocity QALY : Quality adjusted life years RAA : renin-angiotensin-aldosterone RAS : renin-angiotensin system RCT : randomized controlled trials RF : risk factor ROADMAP : Randomized Olmesartan And Diabetes MicroAlbuminuria Prevention SBP : systolic blood pressure SCAST : Angiotensin-Receptor Blocker Candesartan for Treatment of Acute STroke SCOPE : Study on COgnition and Prognosis in the Elderly SCORE : Systematic COronary Risk Evaluation SHEP : Systolic Hypertension in the Elderly Program STOP : Swedish Trials in Old Patients with Hypertension STOP-2 : The second Swedish Trial in Old Patients with Hypertension SYSTCHINA : SYSTolic Hypertension in the Elderly: Chinese trial SYSTEUR : SYSTolic Hypertension in Europe TIA : transient ischaemic attack TOHP : Trials Of Hypertension Prevention TRANSCEND : Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease UKPDS : United Kingdom Prospective Diabetes Study VADT : Veterans' Affairs Diabetes Trial VALUE : Valsartan Antihypertensive Long-term Use Evaluation WHO : World Health Organization ### 1.1 Principles The 2013 guidelines on hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology …

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results